Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation.
about
Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.What is new in non-muscle-invasive bladder cancer in 2016?Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy.A single immediate instillation of chemotherapy for non-muscle invasive bladder cancer: in all patients?
P2860
Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prediction model for recurrenc ...... including external validation.
@ast
Prediction model for recurrenc ...... including external validation.
@en
type
label
Prediction model for recurrenc ...... including external validation.
@ast
Prediction model for recurrenc ...... including external validation.
@en
prefLabel
Prediction model for recurrenc ...... including external validation.
@ast
Prediction model for recurrenc ...... including external validation.
@en
P2093
P2860
P1476
Prediction model for recurrenc ...... including external validation.
@en
P2093
J Alfred Witjes
Jan C M Hendriks
Joan Palou
O Rodriguez Faba Rodriguez Faba
Rianne J M Lammers
Wim P J Witjes
P2860
P2888
P304
P356
10.1007/S00345-015-1598-0
P577
2015-05-30T00:00:00Z